Thomas W. Matthes

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

TimeFlow 2: An Unsupervised Cell Lineage Detection Method for Flow Cytometry Data.

TimeFlow 2: An Unsupervised Cell Lineage Detection Method for Flow Cytometry Data.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: July 25, 2025

TimeFlow: A Density-Driven Pseudotime Method for Flow Cytometry Data Analysis.

TimeFlow: A Density-Driven Pseudotime Method for Flow Cytometry Data Analysis.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: July 25, 2024

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Journal: Cancers
Published: April 15, 2024

Phenotypic Analysis of Hematopoietic Stem and Progenitor Cell Populations in Acute Myeloid Leukemia Based on Spectral Flow Cytometry, a 20-Color Panel, and Unsupervised Learning Algorithms.

Phenotypic Analysis of Hematopoietic Stem and Progenitor Cell Populations in Acute Myeloid Leukemia Based on Spectral Flow Cytometry, a 20-Color Panel, and Unsupervised Learning Algorithms.

Journal: International journal of molecular sciences
Published: February 03, 2024

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

Journal: Nature cancer
Published: October 09, 2023

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Journal: Nature communications
Published: July 31, 2023

Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia

Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia

Journal: Revue medicale suisse
Published: April 05, 2023

Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.

Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.

Journal: Cells
Published: February 17, 2023

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.

Journal: Blood
Published: December 27, 2022

Microarrayed human bone marrow organoids for modeling blood stem cell dynamics.

Microarrayed human bone marrow organoids for modeling blood stem cell dynamics.

Journal: APL bioengineering
Published: March 24, 2022

Quantification and Phenotypic Characterization of Extracellular Vesicles from Patients with Acute Myeloid and B-Cell Lymphoblastic Leukemia.

Quantification and Phenotypic Characterization of Extracellular Vesicles from Patients with Acute Myeloid and B-Cell Lymphoblastic Leukemia.

Journal: Cancers
Published: November 25, 2021

Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.

Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.

Journal: Journal of cancer research and clinical oncology
Published: October 13, 2021
Showing 1-12 of 44

Last Updated: 09/26/2026